145 related articles for article (PubMed ID: 32782622)
1. Comparison of the diagnostic value of CEA combined with OPN or DKK1 in non-small cell lung cancer.
Sun J; Chen X; Wang Y
Oncol Lett; 2020 Sep; 20(3):3046-3052. PubMed ID: 32782622
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
3. Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.
Byeon H; Lee SD; Hong EK; Lee DE; Kim BH; Seo Y; Joo J; Han SS; Kim SH; Park SJ
Pathol Res Pract; 2018 Jun; 214(6):814-820. PubMed ID: 29753515
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.
Wang P; Li C; Zhang F; Ma X; Gai X
Dis Markers; 2018; 2018():4310790. PubMed ID: 30363700
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of serum CircERBB2 level in NSCLC and its correlation with clinicopathological features in NSCLC patients.
Zou G; Lu W; Dai X
Am J Transl Res; 2023; 15(2):1215-1222. PubMed ID: 36915755
[TBL] [Abstract][Full Text] [Related]
6. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
[TBL] [Abstract][Full Text] [Related]
7. Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?
Ayan AK; Erdemci B; Orsal E; Bayraktutan Z; Akpinar E; Topcu A; Turkeli M; Seven B
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):102-6. PubMed ID: 26521996
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis Value of Combined Detection of Serum SF, CEA and CRP in Non-Small Cell Lung Cancer.
Zhou J; Diao X; Wang S; Yao Y
Cancer Manag Res; 2020; 12():8813-8819. PubMed ID: 33061577
[TBL] [Abstract][Full Text] [Related]
9. Plasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancer.
Han SS; Lee SJ; Kim WJ; Ryu DR; Won JY; Park S; Cheon MJ
Tuberc Respir Dis (Seoul); 2013 Sep; 75(3):104-10. PubMed ID: 24101934
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Seven Autoantibodies Combined with CEA and CA199 in Non-Small Cell Lung Cancer.
Xie F; Xu L; Mu Y; Zhang R; Li J; Xu G
Clin Lab; 2023 May; 69(5):. PubMed ID: 37145062
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of ADAM8 and CEA in serum of patients with non-small cell lung cancer.].
Huang J; Chen F; Wu Y; Yang J
Zhongguo Fei Ai Za Zhi; 2008 Dec; 11(6):789-92. PubMed ID: 20797330
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
13. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.
Ma R; Xu H; Wu J; Sharma A; Bai S; Dun B; Jing C; Cao H; Wang Z; She JX; Feng J
Oncotarget; 2017 Mar; 8(12):18901-18913. PubMed ID: 28121629
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
16. Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer.
Shang L; Zhang W; Wu H; Wu R; Chen R
Evid Based Complement Alternat Med; 2021; 2021():1436088. PubMed ID: 34691202
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease.
Chen F; Wang XY; Han XH; Wang H; Qi J
Int J Clin Exp Med; 2015; 8(7):11295-300. PubMed ID: 26379938
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
Song Y; Li H; Jiang Q; Wu L
Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
[TBL] [Abstract][Full Text] [Related]
19. Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China.
Yang Y; Chen K; Zhou Y; Hu Z; Chen S; Huang Y
Onco Targets Ther; 2018; 11():587-597. PubMed ID: 29430184
[TBL] [Abstract][Full Text] [Related]
20. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
